Clinical Management Guidelines for Intrahepatic Cholestasis of Pregnancy

作     者：Obstetrics Group of the Gynecology and Obstetrics Branch of Chinese Medical Association Perinatal Medicine Branch of Chinese Medical Association Xinyang Yu Huixia Yang Hongbo Qi 

作者机构：不详 Medical UniversityChongqing 400016China Department of Obstetrics and GynecologyPeking University First HospitalBeijing 100034China Department of Obstetrics and GynecologyWomen and Children's Hospital of Chongqing Medical UniversityChongqing 401147China 

出 版 物：《Maternal-Fetal Medicine》 (母胎医学杂志（英文）)

年 卷 期：2024年第6卷第1期

页      面：13-22页

核心收录：

学科分类：1002[医学-临床医学] 100211[医学-妇产科学] 10[医学] 

基　　金：supported by National Key Research and Development Program of China (2022YFC2704702) 

主　　题：Cholestasis,Intrahepatic Bile Acids Stillbirth Preterm Birth Diagnostic and Therapeutic Guidelines(Theme) 

摘      要：Intrahepatic cholestasis of pregnancy(ICP)is a significant gestational complication in late pregnancy,potentially leading to severe perinatal complications such as intrauterine fetal demise and preterm *** Obstetrics Group of the Gynecology and Obstetrics Branch and the Perinatal Medicine Branch of the Chinese Medical Association organized a panel of domestic experts to deliberate and propose recommendations based on domestic and international guidelines,recent evidence-based medical evidence about key clinical issues including risk factors,clinical manifestations,perinatal outcomes,diagnosis,severity grading,maternal and fetal monitoring,treatment methods,timing,and methods of pregnancy termination,and postpartum follow-up for ICP,with the aim to guide its clinical diagnosis,treatment,and management.